<DOC>
	<DOC>NCT01150123</DOC>
	<brief_summary>This study will evaluate the safety and immunogenicity of a Group B Streptococcus vaccine.</brief_summary>
	<brief_title>Safety and Immunogenicity of a Group B Streptococcus Vaccine in Healthy Women</brief_title>
	<detailed_description />
	<mesh_term>Vaccines</mesh_term>
	<criteria>Healthy females 1840 years of age inclusive. Individuals who are pregnant or nursing. Individuals who have had a previous immunization with a vaccine containing streptococcus antigens or any vaccine within 30 days of enrollment through 30 days of study completion. Individuals with a history of severe allergic reactions after previous vaccination Individuals with designated blood tests that are not within normal range</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>Group B streptococcus</keyword>
	<keyword>GBS</keyword>
	<keyword>Vaccine</keyword>
	<keyword>Group B streptococcus (GBS) disease</keyword>
</DOC>